August 16, 2024
The US Food and Drug Administration (FDA) has approved durvalumab (Imfinzi; AstraZeneca) both before and after surgery in patients with resectable non–small cell lung cancer (NSCLC) […]
August 16, 2024
TOPLINE: Integrating patient-reported outcome measures (PROMs) into cancer care was associated with improved overall survival and health-related quality-of-life (QoL) in the short-term, though not emergency department […]
August 15, 2024
(Reuters) – Incyte said on Thursday its drug met the main goal in a late-stage trial evaluating it in patients with a form of blood cancer. […]
August 15, 2024
(Reuters) – Bayer won a legal victory in its fight to limit liability from claims its Roundup weed killer causes cancer, as a U.S. appeals court […]
August 15, 2024
TOPLINE: The Breast Cancer Index (BCI) can predict which premenopausal women with hormone receptor–positive breast cancer benefit from ovarian function suppression (OFS) therapy. Women with BCI […]
August 15, 2024
TOPLINE: Women with endometriosis show a higher risk for ovarian cancer, and the magnitude varies with the subtype of endometriosis, with the highest risk seen in […]
August 14, 2024
The US Food and Drug Administration (FDA) has approved axatilimab (Niktimvo, Incyte Corporation) for the treatment of adult and pediatric patients with chronic graft versus host […]
August 14, 2024
Blood cancer death rates have dipped in recent decades, dramatically boosting 5-year survival rates in leukemia, lymphoma, and myeloma. Still, the three diseases were expected to […]
August 14, 2024
The European Commission has approved a combination of an immunotherapy agent with a poly (ADP-ribose) polymerase (PARP) inhibitor for the treatment of certain patients with primary […]